Erste Asset Management GmbH »

Enliven Therapeutics shares owned by Erste Asset Management GmbH

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Erste Asset Management GmbH from 13F filings

Historical chart of Erste Asset Management GmbH investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Erste Asset Management GmbH consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Erste Asset Management GmbH

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.3M 25k 50.85

More positions owned by Erste Asset Management GmbH

Intel Corp Common Stock (INTC)
Starbucks Corp Common Stock (SBUX)
Home Depot Common Stock (HD)
Nvidia Corporation Common Stock (NVDA)
Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Alphabet Common Stock (GOOGL)
Broadcom Common Stock (AVGO)
Lam Research Corp Common Stock (LRCX)
Target Corp Common Stock (TGT)
Amazon Common Stock (AMZN)
Visa Common Stock (V)
Micron Technology Common Stock (MU)
Jpmorgan Chase & Co Common Stock (JPM)
Kla Corp Common Stock (KLAC)

View all positions for Erste Asset Management GmbH

Top funds holding Enliven Therapeutics

FMR
OrbiMed Advisors
Polar Capital Holdings
BlackRock
Vestal Point Capital
Commodore Capital
Vanguard Capital Management
Citadel Advisors
Fairmount Funds Management
Siren
Bellevue Group
Geode Capital Management
First Light Asset Management
Pictet Asset Management Holding SA
State Street Corporation

View all funds holding Enliven Therapeutics